These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome]. Erkebaeva SK; Nurguzhaev ES; Gafurov BG; Tuksanbaeva GU Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):32-6. PubMed ID: 23257743 [TBL] [Abstract][Full Text] [Related]
49. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder]. Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767 [TBL] [Abstract][Full Text] [Related]
50. [SUBSTANTIATION OF INDICATIONS FOR BIOFEEDBACK THERAPY AND CYTOFLAVIN APPLICATION IN TREATMENT OF OSTEOCHONDROSIS NEUROLOGICAL COMPLICATIONS IN ELDERLY PATIENTS]. Parfenov Y; Vasilevskaya M; Parfenov S; Sapozhnikov K; Kovalenko A; Zaplutanov V Georgian Med News; 2018 Oct; (283):89-96. PubMed ID: 30516501 [TBL] [Abstract][Full Text] [Related]
51. [Antioxidant therapy in discirculatory encephalopathy]. Antipenko EA; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819 [No Abstract] [Full Text] [Related]
52. [Use of metabolic drugs and psychotherapy in dental implantation in elderly patients]. Parfenov SA; Volodina KI; Vorob'eva NV Stomatologiia (Mosk); 2013; 92(5):40-3. PubMed ID: 24300707 [TBL] [Abstract][Full Text] [Related]
53. [COGNITIVE ABNORMALITIES IN POSTOPERATIVE PERIOD OF THYROID SURGERY]. Golub IY; Beloborodov VA; Sorokina LV; Kur'yanov AA; Borisova VM Vestn Khir Im I I Grek; 2015; 174(4):53-5. PubMed ID: 26601519 [TBL] [Abstract][Full Text] [Related]
54. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning]. Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536 [TBL] [Abstract][Full Text] [Related]
55. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
56. [Pathogenetic aspects of the use of cytoflavine in the treatment of сhronic post-traumatic headache]. Iskra DA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):41-44. PubMed ID: 28091500 [TBL] [Abstract][Full Text] [Related]
57. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction]. Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870 [TBL] [Abstract][Full Text] [Related]
58. [Prevention of cognitive dysfunction in elderly cancer patients operated on the pelvic organs in conditions of multimodal anesthesia]. Tumanyan SV; Shepelenko AV; Chekmezova SA Khirurgiia (Mosk); 2018; (11):44-48. PubMed ID: 30531753 [TBL] [Abstract][Full Text] [Related]
59. [Gerontological trends of contemporary forms of alcohol dependence. Approaches to full compensation and rehabilitation]. Kovalenko AL; Sosin IK; D'iachenko TV; Chuev IuF; Goncharova EIu; Skalyga IM; Kasparevich AIu; Krivosheeva MD Adv Gerontol; 2014; 27(3):553-9. PubMed ID: 25827006 [TBL] [Abstract][Full Text] [Related]
60. [Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disorders]. Mazin PV; Sheshunov IV; Mazina NK Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):28-39. PubMed ID: 28399094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]